Similar articles for PMID: 23338612

Year	Number of Results
2003	2
2004	1
2005	1
2006	1
2007	2
2008	2
2010	4
2011	1
2012	7
2013	4
2014	2
2015	12
2016	13
2017	8
2018	8
2019	8
2020	14
2021	2
2024	0

1

Collections of simultaneously altered genes as biomarkers of cancer cell drug response.

Masica DL, Karchin R. Masica DL, et al. Cancer Res. 2013 Mar 15;73(6):1699-708. doi: 10.1158/0008-5472.CAN-12-3122. Epub 2013 Jan 21. Cancer Res. 2013. PMID: 23338612 Free PMC article.

2

Individualized genetic network analysis reveals new therapeutic vulnerabilities in 6,700 cancer genomes.

Liu C, Zhao J, Lu W, Dai Y, Hockings J, Zhou Y, Nussinov R, Eng C, Cheng F. Liu C, et al. PLoS Comput Biol. 2020 Feb 26;16(2):e1007701. doi: 10.1371/journal.pcbi.1007701. eCollection 2020 Feb. PLoS Comput Biol. 2020. PMID: 32101536 Free PMC article.

3

Oncology and Pharmacogenomics Insights in Polycystic Ovary Syndrome: An Integrative Analysis.

Yumiceba V, López-Cortés A, Pérez-Villa A, Yumiseba I, Guerrero S, García-Cárdenas JM, Armendáriz-Castillo I, Guevara-Ramírez P, Leone PE, Zambrano AK, Paz-Y-Miño C. Yumiceba V, et al. Front Endocrinol (Lausanne). 2020 Oct 26;11:585130. doi: 10.3389/fendo.2020.585130. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 33329391 Free PMC article. Review.

4

Discovering novel pharmacogenomic biomarkers by imputing drug response in cancer patients from large genomics studies.

Geeleher P, Zhang Z, Wang F, Gruener RF, Nath A, Morrison G, Bhutra S, Grossman RL, Huang RS. Geeleher P, et al. Genome Res. 2017 Oct;27(10):1743-1751. doi: 10.1101/gr.221077.117. Epub 2017 Aug 28. Genome Res. 2017. PMID: 28847918 Free PMC article.

5

Database of genomic biomarkers for cancer drugs and clinical targetability in solid tumors.

Dienstmann R, Jang IS, Bot B, Friend S, Guinney J. Dienstmann R, et al. Cancer Discov. 2015 Feb;5(2):118-23. doi: 10.1158/2159-8290.CD-14-1118. Cancer Discov. 2015. PMID: 25656898 Free PMC article.

6

PanDrugs: a novel method to prioritize anticancer drug treatments according to individual genomic data.

Piñeiro-Yáñez E, Reboiro-Jato M, Gómez-López G, Perales-Patón J, Troulé K, Rodríguez JM, Tejero H, Shimamura T, López-Casas PP, Carretero J, Valencia A, Hidalgo M, Glez-Peña D, Al-Shahrour F. Piñeiro-Yáñez E, et al. Genome Med. 2018 May 31;10(1):41. doi: 10.1186/s13073-018-0546-1. Genome Med. 2018. PMID: 29848362 Free PMC article.

7

Pharmacogenetics and pharmacogenomics as tools in cancer therapy.

Rodríguez-Vicente AE, Lumbreras E, Hernández JM, Martín M, Calles A, Otín CL, Algarra SM, Páez D, Taron M. Rodríguez-Vicente AE, et al. Drug Metab Pers Ther. 2016 Mar;31(1):25-34. doi: 10.1515/dmpt-2015-0042. Drug Metab Pers Ther. 2016. PMID: 26863347 Free article. Review.

8

New tools for old drugs: Functional genetic screens to optimize current chemotherapy.

Gerhards NM, Rottenberg S. Gerhards NM, et al. Drug Resist Updat. 2018 Jan;36:30-46. doi: 10.1016/j.drup.2018.01.001. Epub 2018 Jan 12. Drug Resist Updat. 2018. PMID: 29499836 Free PMC article. Review.

9

Data Mining Approaches for Genomic Biomarker Development: Applications Using Drug Screening Data from the Cancer Genome Project and the Cancer Cell Line Encyclopedia.

Covell DG. Covell DG. PLoS One. 2015 Jul 1;10(7):e0127433. doi: 10.1371/journal.pone.0127433. eCollection 2015. PLoS One. 2015. PMID: 26132924 Free PMC article.

10

Pharmacogenetics and pharmacogenomics as new tools to optimise cancer chemotherapy.

Robert J. Robert J. J Chemother. 2004 Nov;16 Suppl 4:22-4. doi: 10.1179/joc.2004.16.Supplement-1.22. J Chemother. 2004. PMID: 15688604 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

85 results

Results by year